Jefferies Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.6M Buy
145,647
+67,250
+86% +$22.1M 0.29% 55
2025
Q4
$27.5M Buy
78,397
+65,288
+498% +$22.1M 0.14% 142
2025
Q3
$4.24M Buy
13,109
+12,451
+1,892% +$3.87M 0.02% 415
2025
Q2
$256K Sell
658
-4,620
-88% -$1.86M ﹤0.01% 1070
2025
Q1
$2.3M Sell
5,278
-17,057
-76% -$6.85M 0.02% 525
2024
Q4
$8.24M Sell
22,335
-3,504
-14% -$1.47M 0.05% 261
2024
Q3
$13.4M Buy
25,839
+7,416
+40% +$3.96M 0.1% 130
2024
Q2
$9.98M Sell
18,423
-11,836
-39% -$6.26M 0.11% 156
2024
Q1
$15.7M Buy
30,259
+6,467
+27% +$3.22M 0.15% 110
2023
Q4
$11.2M Buy
23,792
+18,958
+392% +$8.77M 0.07% 201
2023
Q3
$2.1M Buy
4,834
+4,006
+484% +$1.82M 0.02% 612
2023
Q2
$368K Sell
828
-2,097
-72% -$967K ﹤0.01% 1269
2023
Q1
$1.34M Buy
2,925
+962
+49% +$458K 0.01% 785
2022
Q4
$1.01M Buy
+1,963
New +$997K 0.01% 874

Other funds holding ELV

Jefferies Financial Group's ELV Position: Q1 2026 in Review

Jefferies Financial Group increased its Elevance Health (ELV) stake by 86% in Q1 2026, buying an estimated $22.1M and bringing the position to 145,647 shares worth $42.6M. The position accounts for 0.29% of the portfolio, ranked #55.

Jefferies Financial Group first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Jefferies Financial Group held 145,647 shares of Elevance Health worth $42.6M as of Q1 2026.
  • Jefferies Financial Group bought 67,250 Elevance Health shares in Q1 2026, an estimated $22.1M.
  • Elevance Health made up 0.29% of Jefferies Financial Group's portfolio in Q1 2026, its #55 holding.
  • Jefferies Financial Group first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.